Preliminary studies show conolidine may inhibit particular ion channels, lowering neuronal excitability and restricting soreness alerts. This system is especially appropriate in neuropathic soreness, where by irregular signaling results in persistent distress. Also, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to